Otro
Effect of Bacillus circulans D1 thermostable xylanase on biobleaching of eucalyptus kraft pulp
Registro en:
Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology, v. 106, n. 1-3, p. 393-402, 2003.
0273-2289
10.1385/ABAB:106:1-3:393
WOS:000182725000036
2-s2.0-0038071730
Autor
Bocchini, Daniela A.
Damiano, Valquiria B.
Gomes, Eleni
Da Silva, Roberto
Resumen
The alkalophilic Bacillus circulans D1 was isolated from decayed wood. It produced high levels of extracellular cellulase-free xylanase. The enzyme was thermally stable up to 60°C, with an optimal hydrolysis temperature of 70°C. It was stable over a wide pH range (5.5-10.5), with an optimum pH at 5.5 and 80% of its activity at pH 9.0. This cellulase-free xylanase preparation was used to biobleach kraft pulp. Enzymatic treatment of kraft pulp decreased chlorine dioxide use by 23 and 37% to obtain the same kappa number (κ number) and brightness, respectively. Separation on Sephadex G-50 isolated three fractions with xylanase activity with distinct molecular weights.
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Chorismate synthase: An attractive target for drug development against orphan diseases
Dias, Marcio V.B.; Ely, Fernanda; Palma, Mario Sergio; Azevedo Jr., Walter F. de; Basso, Luiz A.; Santos, Diógenes S. -
Chorismate synthase: An attractive target for drug development against orphan diseases
Universidade Estadual Paulista (Unesp); Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) (2007-03-01)The increase in incidence of infectious diseases worldwide, particularly in developing countries, is worrying. Each year, 14 million people are killed by infectious diseases, mainly HIV/AIDS, respiratory infections, malaria ... -
Chorismate synthase: An attractive target for drug development against orphan diseases
Universidade Estadual Paulista (Unesp); Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) (2007-03-01)The increase in incidence of infectious diseases worldwide, particularly in developing countries, is worrying. Each year, 14 million people are killed by infectious diseases, mainly HIV/AIDS, respiratory infections, malaria ...